Markus J. Cappel serves as Executive at ChemoCentryx, Inc., where they oversee executive responsibilities. Since joining the company, Markus J. Cappel has executed 207 insider transactions totaling $40.4M, demonstrating a bearish approach to their equity position. Their most recent transaction on Oct 19, 2012 involved exercising options for 2,900 shares valued at $1.7K.
Markus J. Cappel currently holds 87,658 shares of ChemoCentryx, Inc. (CCXI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Markus J. Cappel has been a net seller of CCXI stock. They have purchased $0 and sold $40.4M worth of shares.
Markus J. Cappel's most recent insider trade was on Oct 19, 2012, when they sold 2,900 shares at $0.60 per share.
Get notified when new Form 4 filings are submitted
| $10.83 |
| Discretionary |
| Oct 18, 2012 | CCXI | $2.5K | Option Exercise | 4,136 | $0.60 | Discretionary |
| Oct 18, 2012 | CCXI | $15.3K | Option Exercise | 3,566 | $4.30 | Discretionary |
| Sep 25, 2012 | CCXI | $64.7K | Sale | 5,459 | $11.86 | Discretionary |
| Sep 25, 2012 | CCXI | $2.2K | Option Exercise | 3,676 | $0.60 | Discretionary |
| Sep 25, 2012 | CCXI | $7.7K | Option Exercise | 1,783 | $4.30 | Discretionary |